Concert Pharmaceuticals

+$0.04 (+1.25%) As of 3:28 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNCE and other ETFs, options, and stocks.

About CNCE

Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders.

CEO
Roger D. Tung
Employees
71
Headquarters
Lexington, Massachusetts
Founded
2006

CNCE Key Statistics

Market cap
126.68M
Price-Earnings ratio
—
Dividend yield
—
Average volume
165.52K
High today
$3.66
Low today
$3.51
Open price
$3.61
Volume
10.02K
52 Week high
$13.50
52 Week low
$2.64

CNCE Earnings

-$0.81
-$0.49
-$0.16
$0.16
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 24, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure